L’ASSOMPTION, Quebec, April 14, 2022 (GLOBE NEWSWIRE) — Terranueva Corporation (CSE:TEQ) (“Terranueva” or the “Corporation”) is pleased to announce the results of its annual and special meeting of shareholders which took place was held on April 14, 2022. The shareholders, by majority vote, approved a resolution for the election of the following directors: Sylvain Aird, Marc-André Aubé, Marianne Fortier-Landry, Gérard Landry, Jean-Luc Landry, Peter Polatos and Sylvain Tremblay. The shareholders, by a majority of votes, also proceeded to the appointment of PricewaterhouseCoopers srl/sencrl as auditors of the Company as well as approved the plan for the allocation of stock options at a fixed number of the Company so as to increase to 4,596,996 the maximum number of ordinary shares that may be issued following the exercise of options, which represents 10% of the number of ordinary shares of Terranueva’s share capital on the reference date of the March 14, 2022.
Terranueva relies on research and development, innovation and operational efficiency to become a key player in the emerging cannabis industry. Its goal is to provide the Canadian and international markets with top quality medical and recreational cannabis. To achieve its objective, Terranueva implements a modular production approach incorporating the latest advances and innovations in the automation of these processes. Terranueva Pharma Corporation, its wholly-owned subsidiary, holds the necessary licenses from Health Canada to carry out its mission.
To learn more about Terranueva, visit www.terranueva.ca.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the CSE policies) accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact:
Jean-Luc Landry, Executive Chairman of the Board and Chief Executive Officer of the Company, Telephone: (450) 591-1011